Skip to main content

Maltz Jules A.'s Form 4 filing

Hims & Hers Health, Inc. (HIMS) · filed Mar 6, 2023

Accession no.
0001209191-23-016370
Filed
Mar 6, 2023
Trade date
Mar 2, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 13 non-derivative transactions. Open-market sales total $371.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maltz Jules A.CIK 000155325410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 2, 2023Class A Common StockJOtherDisposed−2,486,770$0.00$07,668,334Indirect
Mar 2, 2023Class A Common StockJOtherDisposed−13,188$0.00$040,786Indirect
Mar 2, 2023Class A Common StockJOtherDisposed−2,500,000$0.00$07,709,091Indirect
Mar 2, 2023Class A Common StockJOtherAcquired+537,143$0.00$0537,143Indirect
Mar 2, 2023Class A Common StockJOtherDisposed−537,143$0.00$00Indirect
Mar 2, 2023Class A Common StockJOtherAcquired+33,180$0.00$033,180Indirect
Mar 2, 2023Class A Common StockJOtherAcquired+62,500$0.00$062,500Indirect
Mar 2, 2023Class A Common StockJOtherDisposed−62,500$0.00$00Indirect
Mar 2, 2023Class A Common StockJOtherAcquired+95,401$0.00$0220,401Indirect
Mar 2, 2023Class A Common StockSSaleDisposed−1,789$10.10F17−$18,068.97,666,545Indirect
Mar 2, 2023Class A Common StockSSaleDisposed−51$10.10F17−$515.140,735Indirect
Mar 2, 2023Class A Common StockSSaleDisposed−1,800$10.10F17−$18,1807,707,291Indirect
Mar 2, 2023Class A Common StockSSaleDisposed−33,180$10.10F17−$335,1180Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)